MDLZ.US Weekly Report · 2026-W36
MDLZ.US retreated 1.73% for the week but underlying fundamentals showed notable resilience. Q2 earnings delivered a 144.9% year-over-year EPS surge and 175% sequential growth, well ahead of consensus. Institutional consensus tilted heavily toward buy, with 15 firms rating buy/strong buy and zero sell ratings. Yet capital flows turned decidedly negative across all investor tiers—retail, institutional, and mid-cap all liquidating—revealing caution about current valuation despite improved earnings. The contradiction between profit acceleration and capital outflow signals market scrutiny of earnings sustainability.
Market Action
Weekly close fell from $62.36 (Aug 28) to $61.28 (Sep 4), a decline of -1.73%. The week’s high reached $63.03 (Sep 2), low $60.91 (Sep 4), creating a 3.45% intraweek swing.
Friday volume was 7.9 million shares; 5-day average ~7.5 million shares, in line with 60-day median—no unusual volume spike. Turnover ratio of 0.62% reflects normal daily activity.
The weekly chart shows initial weakness (Mon-Tue down to $61.61), midweek rebound (Wed $62.45), and late-week decline touching weekly lows ($60.91 on Thu), with modest Friday recovery. The Friday lower wick suggests dip-buying interest near support.
Valuation and Earnings
P/E of 22.24x sits at the 48th percentile of the 5-year range—roughly half the time valuation has been cheaper, placing it in the middle of the historical band. P/B of 2.94 is similarly mid-range; no obvious overvaluation signal.
Earnings proved the week’s centerpiece. Q2 EPS of $1.20 exploded 175% sequentially from Q1’s $0.44 and surged 144.9% year-over-year against Q2 2025’s $0.49. Operating profit jumped 70.62% to $2.056 billion, while revenue grew just 4.13% to $9.355 billion—signaling aggressive cost management. Consensus full-year EPS stands at $3.23; Q2’s contribution of $1.20 leaves $2.03 for the remaining three quarters, implying Q3-Q4 will each contribute roughly $1.01—slightly below Q2’s pace, hinting at potential one-time benefits in this quarter or elevated Q2 comps in the year-ahead comparison.
Capital Flows and Institutional Views
Capital flows deteriorated across the board as of Sep 4, 20:00. Retail investors led outflows, with institutional and mid-cap tiers also reducing exposure. This synchronized three-tier liquidation typically reflects profit-taking or forward-looking caution.
On institutional consensus: 15 firms buy or strong buy, 9 hold, 0 sell. Target price of $69.13 implies 12.8% upside from current levels. However, ratings updated Sep 2, running slightly behind the week’s capital movements and thus partially stale as a real-time signal.
Contradiction and Implications
Earnings acceleration and favorable institutional consensus align on an upside path, underpinning the multiple.
The disconnect surfaces here: valuation sits at the 48th percentile (neither cheap nor expensive), yet capital across all tiers is retreating even as profit printed far better than expected. Markets are likely pricing concern about near-term earnings sustainability or embedding hidden risk premiums. In the near term, this friction could produce sideways consolidation near current lows; if capital sentiment reverses or a fresh catalyst emerges, the stock may converge toward consensus targets.